OtherPublishAheadOfPrint
The Biodistribution and Radiation Dosimetry of the Arg-Gly-Asp Peptide 18F-AH111585 in Healthy Volunteers
Brian J. McParland, Matthew P. Miller, Terence J. Spinks, Laura M. Kenny, Safiye Osman, Mandeep K. Khela, Eric Aboagye, Raoul C. Coombes, Ai-Min Hui and Pamela S. Cohen
Journal of Nuclear Medicine September 2008, DOI: https://doi.org/10.2967/jnumed.108.052126
Brian J. McParland
Matthew P. Miller
Terence J. Spinks
Laura M. Kenny
Safiye Osman
Mandeep K. Khela
Eric Aboagye
Raoul C. Coombes
Ai-Min Hui
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
The Biodistribution and Radiation Dosimetry of the Arg-Gly-Asp Peptide 18F-AH111585 in Healthy Volunteers
Brian J. McParland, Matthew P. Miller, Terence J. Spinks, Laura M. Kenny, Safiye Osman, Mandeep K. Khela, Eric Aboagye, Raoul C. Coombes, Ai-Min Hui, Pamela S. Cohen
Journal of Nuclear Medicine Sep 2008, DOI: 10.2967/jnumed.108.052126
The Biodistribution and Radiation Dosimetry of the Arg-Gly-Asp Peptide 18F-AH111585 in Healthy Volunteers
Brian J. McParland, Matthew P. Miller, Terence J. Spinks, Laura M. Kenny, Safiye Osman, Mandeep K. Khela, Eric Aboagye, Raoul C. Coombes, Ai-Min Hui, Pamela S. Cohen
Journal of Nuclear Medicine Sep 2008, DOI: 10.2967/jnumed.108.052126
Jump to section
Related Articles
Cited By...
- In vivo alpha-V beta-3 integrin expression in human aortic atherosclerosis
- 18F-Alfatide II PET/CT for Identification of Breast Cancer: A Preliminary Clinical Study
- Cardiac {alpha}V{beta}3 integrin expression following acute myocardial infarction in humans
- Multicenter Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors
- 68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer
- 99mTc-3PRGD2 for Integrin Receptor Imaging of Lung Cancer: A Multicenter Study
- PET of αv{beta}3-Integrin and αv{beta}5-Integrin Expression with 18F-Fluciclatide for Assessment of Response to Targeted Therapy: Ready for Prime Time?
- Use of a Novel Arg-Gly-Asp Radioligand, 18F-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy